SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-181015
Filing Date
2024-07-18
Accepted
2024-07-18 16:03:06
Documents
4
Effectiveness Date
2024-07-18

Document Format Files

Seq Description Document Type Size
1 S-8 d873156ds8.htm S-8 52356
2 EX-5.1 d873156dex51.htm EX-5.1 4665
3 EX-23.2 d873156dex232.htm EX-23.2 1469
4 EX-FILING FEES d873156dexfilingfees.htm EX-FILING FEES 16369
  Complete submission text file 0001193125-24-181015.txt   75928
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280878 | Film No.: 241124784
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)